These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19387435)

  • 61. Tool locates alternative sites during bioterrorism.
    Healthcare Benchmarks Qual Improv; 2004 Oct; 11(10):118-20. PubMed ID: 15537069
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bioterrorism: development of large-scale medical readiness using multipoint distance-based simulation training.
    von Lubitz DK; Carrasco B; Fausone CA; Gabbrielli F; Kirk J; Lary MJ; Levine H; Patrcelli F; Pletcher TA; Richir S; Stevens G; Wroblewski G
    Stud Health Technol Inform; 2004; 98():221-7. PubMed ID: 15544275
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Flexible defenses roundtable meeting: promoting the strategic innovation of medical countermeasures.
    Gronvall GK; Matheny J; Smith BT; Mair M; Chamberlain AT; Deitch S; Borio L; Inglesby TV; O'Toole T
    Biosecur Bioterror; 2007 Sep; 5(3):271-7. PubMed ID: 17903096
    [No Abstract]   [Full Text] [Related]  

  • 64. Sentinel bioterrorism responders: are hospital labs ready?
    York M
    MLO Med Lab Obs; 2003 Aug; 35(8):12-7, 19; quiz 22-3. PubMed ID: 12942658
    [No Abstract]   [Full Text] [Related]  

  • 65. Race-specific drugs: regulatory trends and public policy.
    Winickoff DE; Obasogie OK
    Trends Pharmacol Sci; 2008 Jun; 29(6):277-9. PubMed ID: 18453000
    [No Abstract]   [Full Text] [Related]  

  • 66. Prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Nov; 73(217):66293-410. PubMed ID: 19112701
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Leave regulation to the FDA.
    Hughes OC
    Science; 2008 Jul; 321(5888):490. PubMed ID: 18653865
    [No Abstract]   [Full Text] [Related]  

  • 68. Health care personnel response to protect the individual and public health under extreme conditions.
    James JJ
    Disaster Med Public Health Prep; 2009 Jun; 3(2):64-5. PubMed ID: 19491595
    [No Abstract]   [Full Text] [Related]  

  • 69. A sad day for science at the FDA.
    Grant EC
    N Engl J Med; 2005 Dec; 353(24):2619-21; author reply 2619-21. PubMed ID: 16363031
    [No Abstract]   [Full Text] [Related]  

  • 70. Do your biohazard, bioterror, and emergency planning NOW.
    Poutanen SM
    MLO Med Lab Obs; 2007 Feb; 39(2):38, 40-1. PubMed ID: 17375845
    [No Abstract]   [Full Text] [Related]  

  • 71. Why these interesting times shouldn't be ignored.
    Pogue JF
    Healthc Leadersh Manag Rep; 2003 May; 11(5):15. PubMed ID: 12858584
    [No Abstract]   [Full Text] [Related]  

  • 72. US biodefense--shocking and awful.
    Nat Biotechnol; 2007 Jun; 25(6):603. PubMed ID: 17557081
    [No Abstract]   [Full Text] [Related]  

  • 73. Legal issues involving bioterrorism preparedness in New Jersey. An initial discourse.
    Jackson JZ; McBride AF; Robertson JA
    N J Med; 2004 Sep; 101(9 Suppl):9-16. PubMed ID: 15497730
    [No Abstract]   [Full Text] [Related]  

  • 74. Passage of S. 3678: the Pandemic and All-Hazards Preparedness Act.
    Mair M; Maldin B; Smith B
    Biosecur Bioterror; 2007 Mar; 5(1):72-4. PubMed ID: 17437354
    [No Abstract]   [Full Text] [Related]  

  • 75. Emerging technologies for bioweapons defense.
    Nguyen S; Rosen JM; Koop CE
    Stud Health Technol Inform; 2005; 111():356-61. PubMed ID: 15718759
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanded access to Phase II clinical trials in oncology: a step toward increasing scientific validity and compassion.
    Marcee AK
    Food Drug Law J; 2008; 63(2):439-57. PubMed ID: 18561471
    [No Abstract]   [Full Text] [Related]  

  • 77. Liability and disaster relief.
    Dave UV
    J Ky Med Assoc; 2009 Jun; 107(6):201-2. PubMed ID: 19585938
    [No Abstract]   [Full Text] [Related]  

  • 78. Access to clinical devices through nontraditional routes.
    Klepinski RJ
    Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 80. The basics of restrictive covenants.
    Breitenbach RW
    J Am Coll Radiol; 2006 Oct; 3(10):733-4. PubMed ID: 17412162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.